Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
Nicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
The Lancet (2022) Vol. 399, Iss. 10323, pp. 437-446
Open Access | Times Cited: 639

Showing 1-25 of 639 citing articles:

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Tommy Nyberg, Neil M. Ferguson, Sophie Nash, et al.
The Lancet (2022) Vol. 399, Iss. 10332, pp. 1303-1312
Open Access | Times Cited: 1164
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Bo Meng, Adam Abdullahi, Isabella A. T. M. Ferreira, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 706-714
Open Access | Times Cited: 977
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study
Cristina Menni, Ana M. Valdes, Lorenzo Polidori, et al.
The Lancet (2022) Vol. 399, Iss. 10335, pp. 1618-1624
Open Access | Times Cited: 797
SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 479
Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles S. P. Foster, William D. Rawlinson, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 415
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 19, pp. 1804-1816
Open Access | Times Cited: 366
Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California
Joseph A. Lewnard, Vennis Hong, Manish M. Patel, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1933-1943
Open Access | Times Cited: 324
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 282
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada
Ana Cecilia Ulloa, Sarah A. Buchan, Nick Daneman, et al.
JAMA (2022) Vol. 327, Iss. 13, pp. 1286-1286
Open Access | Times Cited: 282
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Ori Magen, Jacob Waxman, Maya Makov-Assif, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 17, pp. 1603-1614
Open Access | Times Cited: 268
Modeling transmission of SARS-CoV-2 Omicron in China
Jun Cai, Xiaowei Deng, Juan Yang, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1468-1475
Open Access | Times Cited: 254
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design
Aziz Sheikh, Steven Kerr, Mark Woolhouse, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 959-966
Open Access | Times Cited: 241
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 216
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1556-1571.e18
Open Access | Times Cited: 213
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 167-167
Open Access | Times Cited: 205
Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
Paul Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 4, pp. 642-652
Open Access | Times Cited: 203
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 203
Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study
Waasila Jassat, Salim S. Abdool Karim, Caroline Mudara, et al.
The Lancet Global Health (2022) Vol. 10, Iss. 7, pp. e961-e969
Open Access | Times Cited: 187
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Rahul K. Suryawanshi, Irene P. Chen, Tongcui Ma, et al.
Nature (2022) Vol. 607, Iss. 7918, pp. 351-355
Open Access | Times Cited: 181
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Samir Bhatt, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 967-976
Open Access | Times Cited: 180
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 178
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments
Donia Bouzid, Benoît Visseaux, Christian Kassasseya, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 6, pp. 831-837
Open Access | Times Cited: 178
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 178
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
Venice Servellita, Abdullah M. Syed, Mary Kate Morris, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1539-1548.e5
Open Access | Times Cited: 162
Page 1 - Next Page

Scroll to top